Micro Emerging Active

JNJ ICOTYDE Shows Promise In Plaque Psoriasis Treatment

New narrative with limited coverage — still forming.

Score
0,3
Vélocité
▲ 0,0
Articles
1
Sources
1

Sentiment Timeline

Event Timeline

Mar 28, 2026
Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis Neutral

Articles Liés

Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis

Nasdaq · Mar 28, 2026
Mixed

Chronologie

Première observationMar 28, 2026
Dernière mise à jourMar 28, 2026